Global Anal Cancer Market Size, Status and Forecast 2020-2026

May 2020 | 126 pages | ID: GDA6746A5B63EN
QYResearch

Abstracts

This report focuses on the global Anal Cancer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Anal Cancer development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• GlaxoSmithKline
• Spectrum Pharmaceuticals
• Hospira
• Global BioPharma
• Advaxis
• Amgen Inc
• Atara Biotherapeutics
• Bayer
• Cell Medica
• Eli Lilly
• Genticel
• ISA Pharmaceuticals
• Merck?Co
• Millennium Pharmaceuticals
• Novartis
• ??Ono Pharmaceutical
• Oryx
• PDS Biotechnology
• Sun Pharma

Market segment by Type, the product can be split into

• Fluorouracil
• Cisplatin
• Carboplatin
• Other

Market segment by Application, split into

• Hospitals
• Long-term care centers
• Pharmacies
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Anal Cancer status, future forecast, growth opportunity, key market and key players.
• To present the Anal Cancer development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Anal Cancer are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Anal Cancer Revenue
1.4 Market Analysis by Type
  1.4.1 Global Anal Cancer Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Fluorouracil
  1.4.3 Cisplatin
  1.4.4 Carboplatin
  1.4.5 Other
1.5 Market by Application
  1.5.1 Global Anal Cancer Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Long-term care centers
  1.5.4 Pharmacies
  1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Anal Cancer Market Perspective (2015-2026)
2.2 Anal Cancer Growth Trends by Regions
  2.2.1 Anal Cancer Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Anal Cancer Historic Market Share by Regions (2015-2020)
  2.2.3 Anal Cancer Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Anal Cancer Market Growth Strategy
  2.3.6 Primary Interviews with Key Anal Cancer Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Anal Cancer Players by Market Size
  3.1.1 Global Top Anal Cancer Players by Revenue (2015-2020)
  3.1.2 Global Anal Cancer Revenue Market Share by Players (2015-2020)
  3.1.3 Global Anal Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Anal Cancer Market Concentration Ratio
  3.2.1 Global Anal Cancer Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Anal Cancer Revenue in 2019
3.3 Anal Cancer Key Players Head office and Area Served
3.4 Key Players Anal Cancer Product Solution and Service
3.5 Date of Enter into Anal Cancer Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Anal Cancer Historic Market Size by Type (2015-2020)
4.2 Global Anal Cancer Forecasted Market Size by Type (2021-2026)

5 ANAL CANCER BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Anal Cancer Market Size by Application (2015-2020)
5.2 Global Anal Cancer Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Anal Cancer Market Size (2015-2020)
6.2 Anal Cancer Key Players in North America (2019-2020)
6.3 North America Anal Cancer Market Size by Type (2015-2020)
6.4 North America Anal Cancer Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Anal Cancer Market Size (2015-2020)
7.2 Anal Cancer Key Players in Europe (2019-2020)
7.3 Europe Anal Cancer Market Size by Type (2015-2020)
7.4 Europe Anal Cancer Market Size by Application (2015-2020)

8 CHINA

8.1 China Anal Cancer Market Size (2015-2020)
8.2 Anal Cancer Key Players in China (2019-2020)
8.3 China Anal Cancer Market Size by Type (2015-2020)
8.4 China Anal Cancer Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Anal Cancer Market Size (2015-2020)
9.2 Anal Cancer Key Players in Japan (2019-2020)
9.3 Japan Anal Cancer Market Size by Type (2015-2020)
9.4 Japan Anal Cancer Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Anal Cancer Market Size (2015-2020)
10.2 Anal Cancer Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Anal Cancer Market Size by Type (2015-2020)
10.4 Southeast Asia Anal Cancer Market Size by Application (2015-2020)

11 INDIA

11.1 India Anal Cancer Market Size (2015-2020)
11.2 Anal Cancer Key Players in India (2019-2020)
11.3 India Anal Cancer Market Size by Type (2015-2020)
11.4 India Anal Cancer Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Anal Cancer Market Size (2015-2020)
12.2 Anal Cancer Key Players in Central & South America (2019-2020)
12.3 Central & South America Anal Cancer Market Size by Type (2015-2020)
12.4 Central & South America Anal Cancer Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 GlaxoSmithKline
  13.1.1 GlaxoSmithKline Company Details
  13.1.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.1.3 GlaxoSmithKline Anal Cancer Introduction
  13.1.4 GlaxoSmithKline Revenue in Anal Cancer Business (2015-2020))
  13.1.5 GlaxoSmithKline Recent Development
13.2 Spectrum Pharmaceuticals
  13.2.1 Spectrum Pharmaceuticals Company Details
  13.2.2 Spectrum Pharmaceuticals Business Overview and Its Total Revenue
  13.2.3 Spectrum Pharmaceuticals Anal Cancer Introduction
  13.2.4 Spectrum Pharmaceuticals Revenue in Anal Cancer Business (2015-2020)
  13.2.5 Spectrum Pharmaceuticals Recent Development
13.3 Hospira
  13.3.1 Hospira Company Details
  13.3.2 Hospira Business Overview and Its Total Revenue
  13.3.3 Hospira Anal Cancer Introduction
  13.3.4 Hospira Revenue in Anal Cancer Business (2015-2020)
  13.3.5 Hospira Recent Development
13.4 Global BioPharma
  13.4.1 Global BioPharma Company Details
  13.4.2 Global BioPharma Business Overview and Its Total Revenue
  13.4.3 Global BioPharma Anal Cancer Introduction
  13.4.4 Global BioPharma Revenue in Anal Cancer Business (2015-2020)
  13.4.5 Global BioPharma Recent Development
13.5 Advaxis
  13.5.1 Advaxis Company Details
  13.5.2 Advaxis Business Overview and Its Total Revenue
  13.5.3 Advaxis Anal Cancer Introduction
  13.5.4 Advaxis Revenue in Anal Cancer Business (2015-2020)
  13.5.5 Advaxis Recent Development
13.6 Amgen Inc
  13.6.1 Amgen Inc Company Details
  13.6.2 Amgen Inc Business Overview and Its Total Revenue
  13.6.3 Amgen Inc Anal Cancer Introduction
  13.6.4 Amgen Inc Revenue in Anal Cancer Business (2015-2020)
  13.6.5 Amgen Inc Recent Development
13.7 Atara Biotherapeutics
  13.7.1 Atara Biotherapeutics Company Details
  13.7.2 Atara Biotherapeutics Business Overview and Its Total Revenue
  13.7.3 Atara Biotherapeutics Anal Cancer Introduction
  13.7.4 Atara Biotherapeutics Revenue in Anal Cancer Business (2015-2020)
  13.7.5 Atara Biotherapeutics Recent Development
13.8 Bayer
  13.8.1 Bayer Company Details
  13.8.2 Bayer Business Overview and Its Total Revenue
  13.8.3 Bayer Anal Cancer Introduction
  13.8.4 Bayer Revenue in Anal Cancer Business (2015-2020)
  13.8.5 Bayer Recent Development
13.9 Cell Medica
  13.9.1 Cell Medica Company Details
  13.9.2 Cell Medica Business Overview and Its Total Revenue
  13.9.3 Cell Medica Anal Cancer Introduction
  13.9.4 Cell Medica Revenue in Anal Cancer Business (2015-2020)
  13.9.5 Cell Medica Recent Development
13.10 Eli Lilly
  13.10.1 Eli Lilly Company Details
  13.10.2 Eli Lilly Business Overview and Its Total Revenue
  13.10.3 Eli Lilly Anal Cancer Introduction
  13.10.4 Eli Lilly Revenue in Anal Cancer Business (2015-2020)
  13.10.5 Eli Lilly Recent Development
13.11 Genticel
  10.11.1 Genticel Company Details
  10.11.2 Genticel Business Overview and Its Total Revenue
  10.11.3 Genticel Anal Cancer Introduction
  10.11.4 Genticel Revenue in Anal Cancer Business (2015-2020)
  10.11.5 Genticel Recent Development
13.12 ISA Pharmaceuticals
  10.12.1 ISA Pharmaceuticals Company Details
  10.12.2 ISA Pharmaceuticals Business Overview and Its Total Revenue
  10.12.3 ISA Pharmaceuticals Anal Cancer Introduction
  10.12.4 ISA Pharmaceuticals Revenue in Anal Cancer Business (2015-2020)
  10.12.5 ISA Pharmaceuticals Recent Development
13.13 Merck?Co
  10.13.1 Merck?Co Company Details
  10.13.2 Merck?Co Business Overview and Its Total Revenue
  10.13.3 Merck?Co Anal Cancer Introduction
  10.13.4 Merck?Co Revenue in Anal Cancer Business (2015-2020)
  10.13.5 Merck?Co Recent Development
13.14 Millennium Pharmaceuticals
  10.14.1 Millennium Pharmaceuticals Company Details
  10.14.2 Millennium Pharmaceuticals Business Overview and Its Total Revenue
  10.14.3 Millennium Pharmaceuticals Anal Cancer Introduction
  10.14.4 Millennium Pharmaceuticals Revenue in Anal Cancer Business (2015-2020)
  10.14.5 Millennium Pharmaceuticals Recent Development
13.15 Novartis
  10.15.1 Novartis Company Details
  10.15.2 Novartis Business Overview and Its Total Revenue
  10.15.3 Novartis Anal Cancer Introduction
  10.15.4 Novartis Revenue in Anal Cancer Business (2015-2020)
  10.15.5 Novartis Recent Development
13.16 ??Ono Pharmaceutical
  10.16.1 ??Ono Pharmaceutical Company Details
  10.16.2 ??Ono Pharmaceutical Business Overview and Its Total Revenue
  10.16.3 ??Ono Pharmaceutical Anal Cancer Introduction
  10.16.4 ??Ono Pharmaceutical Revenue in Anal Cancer Business (2015-2020)
  10.16.5 ??Ono Pharmaceutical Recent Development
13.17 Oryx
  10.17.1 Oryx Company Details
  10.17.2 Oryx Business Overview and Its Total Revenue
  10.17.3 Oryx Anal Cancer Introduction
  10.17.4 Oryx Revenue in Anal Cancer Business (2015-2020)
  10.17.5 Oryx Recent Development
13.18 PDS Biotechnology
  10.18.1 PDS Biotechnology Company Details
  10.18.2 PDS Biotechnology Business Overview and Its Total Revenue
  10.18.3 PDS Biotechnology Anal Cancer Introduction
  10.18.4 PDS Biotechnology Revenue in Anal Cancer Business (2015-2020)
  10.18.5 PDS Biotechnology Recent Development
13.19 Sun Pharma
  10.19.1 Sun Pharma Company Details
  10.19.2 Sun Pharma Business Overview and Its Total Revenue
  10.19.3 Sun Pharma Anal Cancer Introduction
  10.19.4 Sun Pharma Revenue in Anal Cancer Business (2015-2020)
  10.19.5 Sun Pharma Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Anal Cancer Key Market Segments
Table 2. Key Players Covered: Ranking by Anal Cancer Revenue
Table 3. Ranking of Global Top Anal Cancer Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Anal Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Fluorouracil
Table 6. Key Players of Cisplatin
Table 7. Key Players of Carboplatin
Table 8. Key Players of Other
Table 9. Global Anal Cancer Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Anal Cancer Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Anal Cancer Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Anal Cancer Market Share by Regions (2015-2020)
Table 13. Global Anal Cancer Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Anal Cancer Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Anal Cancer Market Growth Strategy
Table 19. Main Points Interviewed from Key Anal Cancer Players
Table 20. Global Anal Cancer Revenue by Players (2015-2020) (Million US$)
Table 21. Global Anal Cancer Market Share by Players (2015-2020)
Table 22. Global Top Anal Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anal Cancer as of 2019)
Table 23. Global Anal Cancer by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Anal Cancer Product Solution and Service
Table 26. Date of Enter into Anal Cancer Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Anal Cancer Market Size by Type (2015-2020) (Million US$)
Table 29. Global Anal Cancer Market Size Share by Type (2015-2020)
Table 30. Global Anal Cancer Revenue Market Share by Type (2021-2026)
Table 31. Global Anal Cancer Market Size Share by Application (2015-2020)
Table 32. Global Anal Cancer Market Size by Application (2015-2020) (Million US$)
Table 33. Global Anal Cancer Market Size Share by Application (2021-2026)
Table 34. North America Key Players Anal Cancer Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Anal Cancer Market Share (2019-2020)
Table 36. North America Anal Cancer Market Size by Type (2015-2020) (Million US$)
Table 37. North America Anal Cancer Market Share by Type (2015-2020)
Table 38. North America Anal Cancer Market Size by Application (2015-2020) (Million US$)
Table 39. North America Anal Cancer Market Share by Application (2015-2020)
Table 40. Europe Key Players Anal Cancer Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Anal Cancer Market Share (2019-2020)
Table 42. Europe Anal Cancer Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Anal Cancer Market Share by Type (2015-2020)
Table 44. Europe Anal Cancer Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Anal Cancer Market Share by Application (2015-2020)
Table 46. China Key Players Anal Cancer Revenue (2019-2020) (Million US$)
Table 47. China Key Players Anal Cancer Market Share (2019-2020)
Table 48. China Anal Cancer Market Size by Type (2015-2020) (Million US$)
Table 49. China Anal Cancer Market Share by Type (2015-2020)
Table 50. China Anal Cancer Market Size by Application (2015-2020) (Million US$)
Table 51. China Anal Cancer Market Share by Application (2015-2020)
Table 52. Japan Key Players Anal Cancer Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Anal Cancer Market Share (2019-2020)
Table 54. Japan Anal Cancer Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Anal Cancer Market Share by Type (2015-2020)
Table 56. Japan Anal Cancer Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Anal Cancer Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Anal Cancer Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Anal Cancer Market Share (2019-2020)
Table 60. Southeast Asia Anal Cancer Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Anal Cancer Market Share by Type (2015-2020)
Table 62. Southeast Asia Anal Cancer Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Anal Cancer Market Share by Application (2015-2020)
Table 64. India Key Players Anal Cancer Revenue (2019-2020) (Million US$)
Table 65. India Key Players Anal Cancer Market Share (2019-2020)
Table 66. India Anal Cancer Market Size by Type (2015-2020) (Million US$)
Table 67. India Anal Cancer Market Share by Type (2015-2020)
Table 68. India Anal Cancer Market Size by Application (2015-2020) (Million US$)
Table 69. India Anal Cancer Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Anal Cancer Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Anal Cancer Market Share (2019-2020)
Table 72. Central & South America Anal Cancer Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Anal Cancer Market Share by Type (2015-2020)
Table 74. Central & South America Anal Cancer Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Anal Cancer Market Share by Application (2015-2020)
Table 76. GlaxoSmithKline Company Details
Table 77. GlaxoSmithKline Business Overview
Table 78. GlaxoSmithKline Product
Table 79. GlaxoSmithKline Revenue in Anal Cancer Business (2015-2020) (Million US$)
Table 80. GlaxoSmithKline Recent Development
Table 81. Spectrum Pharmaceuticals Company Details
Table 82. Spectrum Pharmaceuticals Business Overview
Table 83. Spectrum Pharmaceuticals Product
Table 84. Spectrum Pharmaceuticals Revenue in Anal Cancer Business (2015-2020) (Million US$)
Table 85. Spectrum Pharmaceuticals Recent Development
Table 86. Hospira Company Details
Table 87. Hospira Business Overview
Table 88. Hospira Product
Table 89. Hospira Revenue in Anal Cancer Business (2015-2020) (Million US$)
Table 90. Hospira Recent Development
Table 91. Global BioPharma Company Details
Table 92. Global BioPharma Business Overview
Table 93. Global BioPharma Product
Table 94. Global BioPharma Revenue in Anal Cancer Business (2015-2020) (Million US$)
Table 95. Global BioPharma Recent Development
Table 96. Advaxis Company Details
Table 97. Advaxis Business Overview
Table 98. Advaxis Product
Table 99. Advaxis Revenue in Anal Cancer Business (2015-2020) (Million US$)
Table 100. Advaxis Recent Development
Table 101. Amgen Inc Company Details
Table 102. Amgen Inc Business Overview
Table 103. Amgen Inc Product
Table 104. Amgen Inc Revenue in Anal Cancer Business (2015-2020) (Million US$)
Table 105. Amgen Inc Recent Development
Table 106. Atara Biotherapeutics Company Details
Table 107. Atara Biotherapeutics Business Overview
Table 108. Atara Biotherapeutics Product
Table 109. Atara Biotherapeutics Revenue in Anal Cancer Business (2015-2020) (Million US$)
Table 110. Atara Biotherapeutics Recent Development
Table 111. Bayer Business Overview
Table 112. Bayer Product
Table 113. Bayer Company Details
Table 114. Bayer Revenue in Anal Cancer Business (2015-2020) (Million US$)
Table 115. Bayer Recent Development
Table 116. Cell Medica Company Details
Table 117. Cell Medica Business Overview
Table 118. Cell Medica Product
Table 119. Cell Medica Revenue in Anal Cancer Business (2015-2020) (Million US$)
Table 120. Cell Medica Recent Development
Table 121. Eli Lilly Company Details
Table 122. Eli Lilly Business Overview
Table 123. Eli Lilly Product
Table 124. Eli Lilly Revenue in Anal Cancer Business (2015-2020) (Million US$)
Table 125. Eli Lilly Recent Development
Table 126. Genticel Company Details
Table 127. Genticel Business Overview
Table 128. Genticel Product
Table 129. Genticel Revenue in Anal Cancer Business (2015-2020) (Million US$)
Table 130. Genticel Recent Development
Table 131. ISA Pharmaceuticals Company Details
Table 132. ISA Pharmaceuticals Business Overview
Table 133. ISA Pharmaceuticals Product
Table 134. ISA Pharmaceuticals Revenue in Anal Cancer Business (2015-2020) (Million US$)
Table 135. ISA Pharmaceuticals Recent Development
Table 136. Merck?Co Company Details
Table 137. Merck?Co Business Overview
Table 138. Merck?Co Product
Table 139. Merck?Co Revenue in Anal Cancer Business (2015-2020) (Million US$)
Table 140. Merck?Co Recent Development
Table 141. Millennium Pharmaceuticals Company Details
Table 142. Millennium Pharmaceuticals Business Overview
Table 143. Millennium Pharmaceuticals Product
Table 144. Millennium Pharmaceuticals Revenue in Anal Cancer Business (2015-2020) (Million US$)
Table 145. Millennium Pharmaceuticals Recent Development
Table 146. Novartis Company Details
Table 147. Novartis Business Overview
Table 148. Novartis Product
Table 149. Novartis Revenue in Anal Cancer Business (2015-2020) (Million US$)
Table 150. Novartis Recent Development
Table 151. ??Ono Pharmaceutical Company Details
Table 152. ??Ono Pharmaceutical Business Overview
Table 153. ??Ono Pharmaceutical Product
Table 154. ??Ono Pharmaceutical Revenue in Anal Cancer Business (2015-2020) (Million US$)
Table 155. ??Ono Pharmaceutical Recent Development
Table 156. Oryx Company Details
Table 157. Oryx Business Overview
Table 158. Oryx Product
Table 159. Oryx Revenue in Anal Cancer Business (2015-2020) (Million US$)
Table 160. Oryx Recent Development
Table 161. PDS Biotechnology Company Details
Table 162. PDS Biotechnology Business Overview
Table 163. PDS Biotechnology Product
Table 164. PDS Biotechnology Revenue in Anal Cancer Business (2015-2020) (Million US$)
Table 165. PDS Biotechnology Recent Development
Table 166. Sun Pharma Company Details
Table 167. Sun Pharma Business Overview
Table 168. Sun Pharma Product
Table 169. Sun Pharma Revenue in Anal Cancer Business (2015-2020) (Million US$)
Table 170. Sun Pharma Recent Development
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Anal Cancer Market Share by Type: 2020 VS 2026
Figure 2. Fluorouracil Features
Figure 3. Cisplatin Features
Figure 4. Carboplatin Features
Figure 5. Other Features
Figure 6. Global Anal Cancer Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Long-term care centers Case Studies
Figure 9. Pharmacies Case Studies
Figure 10. Other Case Studies
Figure 11. Anal Cancer Report Years Considered
Figure 12. Global Anal Cancer Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Anal Cancer Market Share by Regions: 2020 VS 2026
Figure 14. Global Anal Cancer Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Anal Cancer Market Share by Players in 2019
Figure 17. Global Top Anal Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anal Cancer as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Anal Cancer Revenue in 2019
Figure 19. North America Anal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Anal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Anal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Anal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Anal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Anal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Anal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. GlaxoSmithKline Revenue Growth Rate in Anal Cancer Business (2015-2020)
Figure 28. Spectrum Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Spectrum Pharmaceuticals Revenue Growth Rate in Anal Cancer Business (2015-2020)
Figure 30. Hospira Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Hospira Revenue Growth Rate in Anal Cancer Business (2015-2020)
Figure 32. Global BioPharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Global BioPharma Revenue Growth Rate in Anal Cancer Business (2015-2020)
Figure 34. Advaxis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Advaxis Revenue Growth Rate in Anal Cancer Business (2015-2020)
Figure 36. Amgen Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Amgen Inc Revenue Growth Rate in Anal Cancer Business (2015-2020)
Figure 38. Atara Biotherapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Atara Biotherapeutics Revenue Growth Rate in Anal Cancer Business (2015-2020)
Figure 40. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Bayer Revenue Growth Rate in Anal Cancer Business (2015-2020)
Figure 42. Cell Medica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Cell Medica Revenue Growth Rate in Anal Cancer Business (2015-2020)
Figure 44. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Eli Lilly Revenue Growth Rate in Anal Cancer Business (2015-2020)
Figure 46. Genticel Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Genticel Revenue Growth Rate in Anal Cancer Business (2015-2020)
Figure 48. ISA Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. ISA Pharmaceuticals Revenue Growth Rate in Anal Cancer Business (2015-2020)
Figure 50. Merck?Co Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Merck?Co Revenue Growth Rate in Anal Cancer Business (2015-2020)
Figure 52. Millennium Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Millennium Pharmaceuticals Revenue Growth Rate in Anal Cancer Business (2015-2020)
Figure 54. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Novartis Revenue Growth Rate in Anal Cancer Business (2015-2020)
Figure 56. ??Ono Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. ??Ono Pharmaceutical Revenue Growth Rate in Anal Cancer Business (2015-2020)
Figure 58. Oryx Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Oryx Revenue Growth Rate in Anal Cancer Business (2015-2020)
Figure 60. PDS Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. PDS Biotechnology Revenue Growth Rate in Anal Cancer Business (2015-2020)
Figure 62. Sun Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Sun Pharma Revenue Growth Rate in Anal Cancer Business (2015-2020)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed